comparemela.com

Latest Breaking News On - Oregon medical research center - Page 1 : comparemela.com

Early Improvement in Prurigo Nodularis With IL-31 Antagonist Maintained at 1 Year

Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis and why it may be "disruptive in the treatment space."

vimarsana © 2020. All Rights Reserved.